Riskpilot← Back to searchSign inGet full accessSKOGEN GROUP AS
ASActiveOrg 889999772Kolonivegen 43, 2072 DalWholesale of pharmaceutical and medical goods · NACE 4646Est. 20061 employeeswww.blostrupmoen.no
Revenue 2024
NOK 1,2M
-21% vs 2023
EBITDA margin
-223.5%
-7% vs 2023
Equity ratio
34.6%
Financial strength
Net profit 2024
NOK -803K
-152% vs 2023
| Revenue | NOK 1,2M | -21% |
| EBITDA | NOK -2,7M | -7% |
| Net profit | NOK -803K | -152% |
| Total assets | NOK 13M | +8% |
| Equity | NOK 4,5M | -15% |
| Employees | 1 | — |
Legal name
SKOGEN GROUP AS
Org number
889999772
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
5. juli 2006
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Forretningsutvikling av datterselskaper. Franchisevirksomhet av produkter og løsninger og annen tjenesteyting overfor eksisterende og nye datterselskaper.
Address
Kolonivegen 43, 2072 Dal
Website
www.blostrupmoen.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 137 | 1 488 | 1 256 | 1 533 | 1 216 |
| Staff expenses | −4 179 | −3 475 | −3 583 | −2 725 | −2 725 |
| EBITDA | −4 843 | −3 555 | −3 819 | −2 547 | −2 718 |
| Depreciation & amort. | 1 384 | −202 | −211 | −164 | −149 |
| EBIT | −3 459 | −3 757 | −4 030 | −2 711 | −2 868 |
| Net financials | 4 990 | 1 328 | 2 972 | 2 392 | 2 065 |
| Profit before tax | 1 531 | −2 429 | −1 058 | −319 | −803 |
| Tax | 618 | −0 | −0 | −0 | −0 |
| Net profit | 913 | −2 429 | −1 058 | −319 | −803 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 20 918 | 12 726 | 13 058 | 12 047 | 13 008 |
| Equity | 9 403 | 6 674 | 5 616 | 5 297 | 4 495 |
| Long-term debt | 8 507 | 4 867 | 6 524 | 6 112 | 5 614 |
| Short-term debt | 3 007 | 1 185 | 918 | 638 | 2 900 |
| Total debt | 11 515 | 6 052 | 7 442 | 6 749 | 8 514 |
EBITDA margin
-223.5%
This company
15.8%
Market median
-1515% vs market
20202024
Equity ratio
34.6%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
-17.9%
This company
18.4%
Market median
-197% vs market
20202024
Net profit margin
-66.0%
This company
8.1%
Market median
-915% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
1.89×
This company
0.62×
Market median
-205% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 5.56% | 5.56% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SKOGEN GROUP AS 
SKOGEN EIENDOMSUTVIKLING ASBoard members of SKOGEN GROUP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Håkon Blostrupmoen | Chairman | 0 companies |
| Sigbjørn Olav Ringvold | Board of Directors | 0 companies |